| 1 |
34735672 | Phosphodiesterase 10A Is a Critical Target for Neuroprotection in a Mouse Model of Ischemic Stroke. | 2022 Jan |
2 |
| 2 |
32378029 | Phosphodiesterase 10A Inhibition Leads to Brain Region-Specific Recovery Based on Stroke Type. | 2021 Apr |
2 |
| 3 |
33907201 | Transcriptional signatures in prefrontal cortex confer vulnerability versus resilience to food and cocaine addiction-like behavior. | 2021 Apr 27 |
1 |
| 4 |
34117108 | Phosphodiesterase 10A Is a Key Mediator of Lung Inflammation. | 2021 Jun 15 |
2 |
| 5 |
34399440 | Pivotal role of phosphodiesterase 10A in the integration of dopamine signals in mice striatal D1 and D2 medium-sized spiny neurones. | 2021 Dec |
3 |
| 6 |
34735298 | Abstract MP265: The Role Of Phosphodiesterase 10a In Tumor Growth And Doxorubicin-induced Cardiotoxicity. | 2021 Sep 3 |
2 |
| 7 |
30354987 | RNA-Sequencing Analysis Revealed a Distinct Motor Cortex Transcriptome in Spontaneously Recovered Mice After Stroke. | 2018 Sep |
3 |
| 8 |
27811172 | TAK-063, a Novel Phosphodiesterase 10A Inhibitor, Protects from Striatal Neurodegeneration and Ameliorates Behavioral Deficits in the R6/2 Mouse Model of Huntington's Disease. | 2017 Jan |
6 |
| 9 |
27896836 | Radiosynthesis and biological evaluation of the new PDE10A radioligand [18 F]AQ28A. | 2017 Jan |
1 |
| 10 |
28115486 | Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of DYT1 Dystonia. | 2017 Feb 22 |
16 |
| 11 |
26522433 | Biochemical and behavioral effects of PDE10A inhibitors: Relationship to target site occupancy. | 2016 Mar |
3 |
| 12 |
25451212 | Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A. | 2015 Feb |
1 |
| 13 |
25762721 | Phosphodiesterase 10A Is Tethered to a Synaptic Signaling Complex in Striatum. | 2015 May 8 |
5 |
| 14 |
25855188 | Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways. | 2015 Apr 8 |
1 |
| 15 |
26465004 | Selective Effects of PDE10A Inhibitors on Striatopallidal Neurons Require Phosphatase Inhibition by DARPP-32 | 2015 Jul-Aug |
4 |
| 16 |
24698799 | Genetic deletion of PDE10A selectively impairs incentive salience attribution and decreases medium spiny neuron excitability. | 2014 Jul 15 |
2 |
| 17 |
23576401 | PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model. | 2013 Aug |
2 |
| 18 |
21130175 | Impaired appetitively as well as aversively motivated behaviors and learning in PDE10A-deficient mice suggest a role for striatal signaling in evaluative salience attribution. | 2011 Mar |
2 |
| 19 |
19765598 | Alterations in gene regulation following inhibition of the striatum-enriched phosphodiesterase, PDE10A. | 2010 Feb |
1 |
| 20 |
18088367 | Increased social interaction in mice deficient of the striatal medium spiny neuron-specific phosphodiesterase 10A2. | 2008 Apr |
4 |
| 21 |
18923023 | Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum. | 2008 Oct 15 |
2 |
| 22 |
12904862 | Cyclic nucleotide phosphodiesterases in pancreatic islets. | 2003 Sep |
1 |
| 23 |
10359840 | Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A. | 1999 Jun 8 |
4 |